Mckesson Stock News

McKesson Corp is expected to report strong earnings on Wednesday as an Omicron-driven surge in demand for COVID-19 vaccines and tests is likely to insulate the drug distributor from tepid sales of oth

Johnson & Johnson and the country''s three major drug distributors agreed Tuesday to pay $590 million to Native American tribes affected by the opioid crisis, according to a proposed settlement . Why it matters: It''s the largest opioid settlement for Native Americans, the Washington Post notes. "American Indians have suffered the highest per capita rate of opioid overdose and are more likely than other group in the United States to die from drug-induced deaths," said Douglas Yankton, chair of the Spirit Lake Nation in North Dakota, in a statement, per AP . "The dollars that will flow to Tribes under this initial settlement will help fund crucial, on-reservation, culturally appropriate opioid treatment services," Yankton added. The big picture: More than 400 tribes sued the companies, alleging that they helped fuel abuse of the addictive painkillers, Bloomberg reports. By the numbers: In Tuesday''s settlement, distributors McKesson, Cardinal Health and AmerisourceBergen have agreed to pay $440 million over seven years to tribes that have been disproportionately impacted by the opioid crisis.

Mckesson Corporation (MCK) shares closed today at 0.5% below its 52 week high of $258.28, giving the company a market cap of $39B. The stock is currently up 3.3% year-to-date, up 48.5% over the past 12 months, and up 93.5% over the past five years. This week, the Dow Jones Industrial Average rose 2.1%, and the S&P 500 rose 2.3%. Trading Activity Trading volume this week was 63.0% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -492.7% The company's stock price performance over the past 12 months beats the peer average by 235.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

The companies have disputed allegations of playing a part in the opioid epidemic. Thousands of lawsuits, at the state and local levels, have been filed.

McKesson (NYSE:MCK) is scheduled to announce Q3 earnings results on Wednesday, Feb. 2, after market close.

Medical Products companies' Q4 results are likely to reflect an increase in COVID-19 testing demand. Let's see how BSX, TMO, HOLX and MCK are poised ahead of their earnings releases.

Mckesson Corporation (MCK) shares closed today at 0.6% below its 52 week high of $258.28, giving the company a market cap of $39B. The stock is currently up 3.9% year-to-date, up 49.3% over the past 12 months, and up 97.5% over the past five years. This week, the Dow Jones Industrial Average rose 1.4%, and the S&P 500 rose 0.9%. Trading Activity Trading volume this week was 1.2% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -1325.1% The company's stock price performance over the past 12 months beats the peer average by 225.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Investors are optimistic about McKesson's (MCK) strength in its Biologics business.

McKesson: It's Time To Consider Buying This SWAN Stock

Mckesson Corporation (MCK) shares closed 0.5% higher than its previous 52 week high, giving the company a market cap of $38B. The stock is currently up 2.6% year-to-date, up 44.5% over the past 12 months, and up 95.7% over the past five years. This week, the Dow Jones Industrial Average fell 1.6%, and the S&P 500 fell 3.5%. Trading Activity Trading volume this week was 39.6% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -235.4% The company's stock price performance over the past 12 months beats the peer average by 281.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Mckesson Corporation (MCK) shares closed today at 0.7% below its 52 week high of $256.85, giving the company a market cap of $37B. The stock is currently down 0.6% year-to-date, up 35.1% over the past 12 months, and up 86.9% over the past five years. This week, the Dow Jones Industrial Average fell 2.5%, and the S&P 500 fell 4.1%. Trading Activity Trading volume this week was 2.2% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Industrials industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -74.7% The company's stock price performance over the past 12 months beats the peer average by 217.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

DUBLIN , Jan. 27, 2022 /PRNewswire/ -- The "Hospital Management Solutions Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com''s offering. The hospital management solutions market size was valued at USD 30.70 billion in 2021 and is expected to reach USD 62.17 billion by 2027, growing at a CAGR of 12.48% during the forecast period. Automation of various hospital management services has played a vital role in increasing the adoption of hospital management systems. Web and cloud-based solutions have major advantages of cost-effectivity, automated workflow, remotely delivering updates, and many others, increasing its demand in the market. With the growing adoption of HMS, vendors are also competing to provide the best software for healthcare organizations. All such factors are promoting the uptake of HMS and thereby contributing to the growth of the market. The following factors are likely to contribute to the growth of the hospital management solutions market are Growing Adoption of RTLS & Cloud Monitoring Enormous Data Mounting in Healthcare Organizations Evolution of Smart Hospital adopting HMS Increasing Need to Manage High Volume of Healthcare Data Updating & Upgrading Healthcare Software Rising Role of AI for Improving Patient Flow and Management Key Highlights AI can potentially help in forecasting patient flow and avoid unnecessary emergency admissions.

McKesson (NYSE:MCK) declares $0.47/share quarterly dividend, in line with previous.Forward yield 0.76%Payable April 1; for shareholders of record March 1; ex-div Feb.

McKesson (MCK) closed at $246.97 in the latest trading session, marking a +0.55% move from the prior day.